RespireRx Pharmaceuticals Inc

États‑Unis d’Amérique

Commandez votre montre hebdomadaire RespireRx Pharmaceuticals Inc
Quantité totale PI 10
Rang # Quantité totale PI 157 711
Note d'activité PI 0,9/5.0    2
Rang # Activité PI 477 515
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

6 1
1 0
2 0
0
 
Dernier brevet 2023 - Lipid nanoparticle compositions ...
Premier brevet 2008 - Di-substituted amides for enhanc...
Dernière marque 1993 - AMPAKINE
Première marque 1993 - AMPAKINE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Lipid nanoparticle compositions and methods for formulating insoluble drugs. The invention provid...
2017 Invention Compositions and methods for treating attention deficit disorders. The present invention relates ...
2013 Invention Di-substituted amides for enhancing glutamatergic synaptic responses. This invention relates to c...
2012 Invention Bicyclic amides for enhancing glutamatergic synaptic responses. This invention relates to bicycli...
Invention Bicyclic amide derivatives for enhancing glutamatergic synaptic responses. This invention relates...
2010 Invention Methods for the treatment of respiratory depression. This invention relates to compounds, pharmac...
Invention Bicyclic amide derivatives for the treatment of respiratory disorders. This invention relates to ...
2008 Invention Bicyclic amides for enhancing glutamatergic synaptic responses. This invention relates to compoun...
Invention Di-substituted amides for enhancing glutamatergic synaptic responses.
This invention r...
1993 P/S pharmaceutical compositions for treatment of deficits in or improvement of memory or cognition